What is the share price of Trident Lifeline Ltd (TLL) today?
The share price of TLL as on 14th July 2025 is ₹267.10. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Trident Lifeline Ltd (TLL) share?
The past returns of Trident Lifeline Ltd (TLL) share are- Past 1 week: -2.14%
- Past 1 month: -2.93%
- Past 3 months: 5.59%
- Past 6 months: -1.19%
- Past 1 year: -9.62%
- Past 3 years: N/A%
- Past 5 years: 148.96%
What are the peers or stocks similar to Trident Lifeline Ltd (TLL)?
The peers or stocks similar to Trident Lifeline Ltd (TLL) include:What is the market cap of Trident Lifeline Ltd (TLL) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Trident Lifeline Ltd (TLL) is ₹312.12 Cr as of 14th July 2025.What is the 52 week high and low of Trident Lifeline Ltd (TLL) share?
The 52-week high of Trident Lifeline Ltd (TLL) is ₹339 and the 52-week low is ₹222.What is the PE and PB ratio of Trident Lifeline Ltd (TLL) stock?
The P/E (price-to-earnings) ratio of Trident Lifeline Ltd (TLL) is 26.56. The P/B (price-to-book) ratio is 5.79.Which sector does Trident Lifeline Ltd (TLL) belong to?
Trident Lifeline Ltd (TLL) belongs to the Health Care sector & Pharmaceuticals sub-sector.How to buy Trident Lifeline Ltd (TLL) shares?
You can directly buy Trident Lifeline Ltd (TLL) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Trident Lifeline Ltd
TLL Share Price
267.100.80% (-2.15)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
TLL Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
AvgFinancials growth has been moderate for a few years
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is overpriced but is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
TLL Performance & Key Metrics
TLL Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 25.99 | 5.79 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 36.72 | 6.42 | 0.79% |
TLL Analyst Ratings & Forecast
—
Analyst Ratings data is currently unavailable for this stockPrice Upside
Earnings Growth
Rev. Growth
TLL Company Profile
Trident Lifeline Ltd produces and sells a wide range of medications, including capsules and syrups, operating in various international markets.
SUNPHARMA
PE Ratio
36.71
36.71
1Y Return
5.71%
5.71%
Buy Reco %
87.10
87.10
CIPLA
PE Ratio
22.75
22.75
1Y Return
1.39%
1.39%
Buy Reco %
73.33
73.33
TORNTPHARM
PE Ratio
58.69
58.69
1Y Return
12.03%
12.03%
Buy Reco %
70.83
70.83
MANKIND
PE Ratio
53.44
53.44
1Y Return
21.78%
21.78%
Buy Reco %
81.25
81.25
DRREDDY
PE Ratio
18.46
18.46
1Y Return
4.87%
4.87%
Buy Reco %
50.00
50.00
TLL Forecast
TLL Forecasts
Forecast data is currently unavailable
Forecast data is currently unavailable
Price
Price Upside
Revenue
Revenue Growth
Earnings
Earnings Per Share
TLL
TLL
Income
Balance Sheet
Cash Flow
Annual Normal View
TLL Income Statement
TLL Income Statement
Annual Normal View
| Financial Year | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 22.37 | 32.85 | 46.71 | 95.20 | 95.36 | |||||
Raw Materials | 14.69 | 23.12 | 30.58 | 72.10 | 72.47 | |||||
| Power & Fuel Cost | 0.02 | 0.10 | 0.26 | |||||||
| Employee Cost | 1.10 | 1.39 | 1.92 | |||||||
| Selling & Administrative Expenses | 0.94 | 1.39 | 1.97 | |||||||
| Operating & Other expenses | 2.31 | -0.56 | 1.67 | |||||||
EBITDA | 3.31 | 7.41 | 10.31 | 23.10 | 22.89 | |||||
| Depreciation/Amortization | 0.20 | 0.36 | 0.97 | 5.49 | 4.98 | |||||
| PBIT | 3.11 | 7.05 | 9.34 | 17.61 | 17.91 | |||||
| Interest & Other Items | 0.13 | 0.48 | 0.65 | 3.99 | 4.03 | |||||
| PBT | 2.98 | 6.57 | 8.69 | 13.62 | 13.88 | |||||
| Taxes & Other Items | -0.96 | 0.56 | 2.35 | 1.87 | 1.87 | |||||
| Net Income | 3.94 | 6.01 | 6.34 | 11.75 | 12.01 | |||||
| EPS | 4.93 | 6.16 | 5.51 | 10.22 | 10.44 | |||||
| DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
| Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
TLL Company Updates
TLL Stock Peers
TLL Past Performance & Peer Comparison
TLL Past Performance & Peer Comparison
Comparing 3 stocks from
Health CarePharmaceuticals
Compare valuation-basic on Screener
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation-basic on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Trident Lifeline Ltd | 26.56 | 5.79 | — |
| Sun Pharmaceutical Industries Ltd | 36.71 | 5.53 | 0.96% |
| Cipla Ltd | 22.75 | 3.83 | 1.08% |
| Torrent Pharmaceuticals Ltd | 58.69 | 14.78 | 0.18% |
TLL Stock Price Comparison
Compare TLL with any stock or ETFCompare TLL with any stock or ETF
TLL
TLL Holdings
TLL Shareholdings
TLL Promoter Holdings Trend
TLL Promoter Holdings Trend
TLL Institutional Holdings Trend
TLL Institutional Holdings Trend
Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
TLL Shareholding Pattern
TLL Shareholding Pattern
TLL Shareholding History
TLL Shareholding History
Foreign Institutions
smallcases containing TLL stock
smallcases containing TLL stock
Looks like this stock is not in any smallcase yet.
TLL Events
TLL Events
TLL Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
TLL has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
TLL Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
TLL has not given any dividends in last 5 years
TLL Dividends
TLL Dividends
Hmm, looks like data is unavailable here. Please come back after some timeTLL Stock News & Opinions
TLL Stock News & Opinions
Articles & Videos
Corporate
Trident Lifeline to convene board meeting
Trident Lifeline will hold a meeting of the Board of Directors of the Company on 28 April 2025.Powered by Capital Market - Live
2 months agoCapital Market - Live
Corporate
Trident Lifeline to convene EGM
Trident Lifeline announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 9 May 2025.Powered by Capital Market - Live
2 months agoCapital Market - Live
Corporate
Trident Lifeline schedules board meeting
Trident Lifeline will hold a meeting of the Board of Directors of the Company on 16 April 2025.Powered by Capital Market - Live
3 months agoCapital Market - Live
Spotlight
Trident Lifeline jumps on collaboration with NIPER-A for Vorinostat, a rare cancer drug
According to an exchange filing, the alliance focuses on transferring the technology for Vorinostat, a key medication used to treat Cutaneous T-Cell Lymphoma (CTCL), a rare blood-originated skin cancer that is currently unavailable in India. This collaboration aims to revolutionize the treatment landscape for CTCL patients by providing access to domestically produced, high-quality Vorinostat. In line with the Make in India initiative, the company plans to scale up production of Vorinostat and introduce it to the Indian market, leveraging NIPER Ahmedabad's expertise. The company also expressed its commitment to social responsibility, stating it would provide Vorinostat free of charge to economically disadvantaged patients. The agreement also emphasizes the creation of affordable cancer treatment options for underserved communities. NIPER Ahmedabad, established in 2007 under the Ministry of Chemicals and Fertilizers, Government of India, is one of seven national institutions focused on promoting quality education and research in pharmaceutical sciences and management. It aims to produce industry-ready human resources for the pharmaceutical sector and conduct advanced research to create quality products. This collaboration is part of Trident Lifeline's Corporate Social Responsibility (CSR) initiative, with the goal of making cancer treatment more accessible to economically challenged individuals in India. Trident Lifeline is engaged in the business of marketing ethical pharmaceutical products in both domestic and international markets. It is also involved in the distribution of pharmaceutical products through a third-party distribution network. The company offers a wide range of pharmaceutical formulations and products manufactured under contract manufacturing on a loan license basis. It operates in India as well as in African, Latin American, and East Asian countries. Currently, it has a presence through registered products or products under registration in countries such as Bolivia, Cambodia, Cameroon, Chile, Ghana, Kenya, Myanmar, Nigeria, Peru, Sudan, Tajikistan, Uzbekistan, and Venezuela. The company's consolidated net profit surged 158.3% to Rs 2.79 crore in Q3 FY25 as against Rs 1.08 crore in Q3 FY24. Revenue from operations jumped 66.9% to Rs 11.83 crore in the quarter ended 31 December 2024. As of 06 March 2025, the company's market capitalization stood at Rs 326.29 crore on the BSE. Powered by Capital Market - Live
4 months agoCapital Market - Live
Earnings
Trident Lifeline consolidated net profit rises 158.33% in the December 2024 quarter
Net profit of Trident Lifeline rose 158.33% to Rs 2.79 crore in the quarter ended December 2024 as against Rs 1.08 crore during the previous quarter ended December 2023. Sales rose 66.85% to Rs 11.83 crore in the quarter ended December 2024 as against Rs 7.09 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales11.837.09 67 OPM %34.4920.03 - PBDT4.081.53 167 PBT3.481.33 162 NP2.791.08 158 Powered by Capital Market - Live
5 months agoCapital Market - Live
Corporate
Trident Lifeline to discuss results
Trident Lifeline will hold a meeting of the Board of Directors of the Company on 22 January 2025.Powered by Capital Market - Live
5 months agoCapital Market - Live
Earnings
Trident Lifeline standalone net profit rises 98.25% in the September 2024 quarter
Net profit of Trident Lifeline rose 98.25% to Rs 3.39 crore in the quarter ended September 2024 as against Rs 1.71 crore during the previous quarter ended September 2023. Sales rose 57.70% to Rs 15.66 crore in the quarter ended September 2024 as against Rs 9.93 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales15.669.93 58 OPM %28.2222.16 - PBDT4.672.47 89 PBT4.512.31 95 NP3.391.71 98 Powered by Capital Market - Live
8 months agoCapital Market - Live
Corporate
Trident Lifeline to announce Quarterly Result
Trident Lifeline will hold a meeting of the Board of Directors of the Company on 19 October 2024.Powered by Capital Market - Live
8 months agoCapital Market - Live
Corporate
Trident Lifeline to hold AGM
Trident Lifeline announced that the Annual General Meeting (AGM) of the company will be held on 20 September 2024.Powered by Capital Market - Live
11 months agoCapital Market - Live
In last 6 months, promoter holding in the company has almost stayed constant
Pledged promoter holdings is insignificant